Sign in
Not yet recruitingNo phase

EEG Changes and Cognitive Profiles in Sepsis Patients With Different Inflammatory Phenotypes

Key facts

Who runs it
Xiangya Hospital of Central South University
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
78 people, planned
Started
1 Aug 2026
Expected to end
1 May 2027
Type of study
Observational, 2 groups
Treatments tested
  • EEG monitoring
Record updated
12 August 2026

Who can take part

Age
18 years to 90 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Age ≥18 years and ≤90 years
  • First-time admission to the Intensive Care Unit (ICU)
  • Diagnosis of sepsis according to Sepsis-3.0 criteria (documented or clinically suspected infection plus Sequential Organ Failure Assessment [SOFA] score ≥2 points)
  • Expected ICU survival time ≥24 hours
  • Written informed consent provided by the patient or legal surrogate

Who cannot take part

  • Pre-existing primary central nervous system (CNS) diseases, including:; Acute cerebrovascular disease (e.g., hemiplegia, cranial nerve palsy) Central nervous system infection (e.g., pleocytosis in cerebrospinal fluid) Organic or metabolic encephalopathy (e.g., hepatic, renal, pulmonary, pancreatic, or severe inherited metabolic disorders) Drug-related encephalopathy (e.g., antipsychotic-associated encephalopathy, serotonin syndrome, neurotoxic antibiotics) Other structural or immunological brain diseases (e.g., traumatic brain injury, intracranial neoplasm, autoimmune encephalopathy)
  • Inability to cooperate with or tolerate scalp EEG electrode placement (e.g., extensive scalp trauma or open scalp infection)
  • Pregnancy or lactation
  • Cardiopulmonary-cerebral resuscitation (CPCR) performed during the current hospital admission

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 90 years old?

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

To characterize the electroencephalogram (EEG) features of sepsis patients with distinct inflammatory response phenotypes, dynamically track their evolutionary trajectories, and analyze their associations with long-term changes in cognitive function.

The 2 groups in the trial

  • High Inflammatory Phenotype Group

    Septic patients displaying serum Interleukin-6 (IL-6) ≥ 400 pg/mL upon ICU admission (Day 1) .

    Treatment: EEG monitoring

  • Low Inflammatory Phenotype Group

    Septic patients displaying serum Interleukin-6 (IL-6) \< 400 pg/mL upon ICU admission (Day 1) .

    Treatment: EEG monitoring

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Electroencephalogram Changes and Cognitive Function Profiles in Sepsis Patients With Different Inflammatory Phenotypes
Criteria questions
Built from NCT07760415, who can take part
Record updated
12 August 2026